©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessArthrogryposis, syndromal; differential diagnosis

Summary

Short information

A curated panel containing 8 core candidate genes and altogether >150 curated genes for the comprehensive analysis of the known genetically caused syndromal forms of arthrogryposis

ID
AP9631
Number of genes
76 Accredited laboratory test
Examined sequence length
20,1 kb (Core-/Core-canditate-Genes)
354,9 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Test material
  • EDTA-anticoagulated blood (3-5 ml)
Diagnostic indications

NGS +

 

Gene panel

Selected genes

NameExon Length (bp)OMIM-GReferenz-Seq.Heredity
CHRNA11374NM_000079.4AD, AR
CHRND1554NM_000751.3AD, AR
CHRNG1554NM_005199.5AR
FKBP101749NM_021939.4AR
FLNB7809NM_001457.4AD, AR
IRF61404NM_006147.4AD
PLOD22277NM_182943.3AR
RIPK42355NM_020639.3AR
ASCC11074NM_001198800.3AR
ASXL14626NM_015338.6AD
BICD22568NM_001003800.2AD
BLTP115018NM_015312.4AR
CHAT2247NM_020549.5AR
CHRNB11506NM_000747.3AD, AR
CHRNE1482NM_000080.4AD, AR
CHST141131NM_130468.4AR
CNTNAP14155NM_003632.3AR
COLQ1368NM_005677.4AR
CRLF11269NM_004750.5AR
DNM22613NM_001005360.3AR
DOK71515NM_173660.5AR
DPAGT11227NM_001382.4AR
DYNC1H113941NM_001376.5AD
EBP693NM_006579.3XL
ERCC64482NM_000124.4AR
ERCC81191NM_000082.4AR
EXOSC3828NM_016042.4AR
FAM20C1755NM_020223.4AR
FGFR22466NM_000141.5AD
FGFR32421NM_000142.5AD, AR
FKTN1386NM_001079802.2AR
FLNA7920NM_001456.4XL
FLNC8178NM_001458.5AD
HSPG213176NM_005529.7AR
KAT6B6222NM_012330.4AD
KIDINS2205431NM_020738.4AR
KLHL71761NM_001031710.3AR
MAGEL23750NM_019066.5AD
MUSK2610NM_005592.4AR
MYH75808NM_000257.4AD, AR
MYH85814NM_002472.3AD
MYMK671NM_001080483.3AR
PEX101041NM_153818.2AR
PEX161011NM_004813.4AR
PEX2918NM_000318.3AR
PEX62943NM_000287.4AR
PEX7972NM_000288.4AR
PIEZO28259NM_022068.4AR, AD
PLOD12184NM_000302.4AR
POMGNT21743NM_032806.6AR
POR2043NM_001395413.1AR
PRG44092NM_005807.6AR
RAPSN1239NM_005055.5AR
RYR115117NM_000540.3AR
SCARF22613NM_153334.7AR
SCN4A5511NM_000334.4AR
SELENON1773NM_020451.3AR
SKI2187NM_003036.4AD
SLC5A71743NM_021815.5AR
SMAD31278NM_005902.4AD
SMAD41659NM_005359.6AD
SMN1885NM_000344.4AR
STAC31095NM_145064.3AR
STIM12058NM_003156.4AD
SYNE126250NM_033071.4AR
TGFB21245NM_003238.6AD
TGFB31239NM_003239.5AD
TGFBR11512NM_004612.4AD
TGFBR21704NM_003242.6AD
TPM2855NM_003289.4AD
TRPV42616NM_021625.5AD
TTN100272NM_001267550.2AR
VAMP1357NM_014231.5AR
VIPAS391482NM_022067.4AR
VPS33B1854NM_018668.5AR
ZC4H2675NM_018684.4XL

Informations about the disease

Clinical Comment

Arthrogryposis is not a specific diagnosis, but a clinical finding that can be a feature of several hundred different conditions. By definition, multiple congenital contractures affect at least two different sites of the body. Distal arthrogryposes represent a subset of these disorders, primarily affecting the distal portions of the limbs. They are characterized by congenital contractures, usually in the absence of primary neurologic and/or muscle disease. Common features of all distal arthrogryposis include a consistent pattern of hand and foot involvement, limited involvement of proximal joints and variable expressivity. Associated features of syndromal arthrogryposis include, with decreasing frequency, brain involvement (cognitive impairment, epilepsy, corpus callosum agenesis, perisylvian polymicrogyria, cerebellar hypoplasia, microcephaly, macrocephaly, ventriculomegaly), intrauterine growth retardation, Cardiac abnormalities (cardiomyopathy, congenital heart defects), facial hemangioma, renal abnormalities (uni-/bilateral pyelectasia, unilateral renal agenesis, renal hypoplasia, urolithiasis), ocular abnormalities (microphthalmos, cataract), hearing loss, unilateral ear hypoplasia, umbilical artery abnormalities and bone agenesis. Amyoplasia is a distinct form of arthrogryposis with characteristic clinical features, that is commonly sporadic. Inheritance patterns for (syndromal) arthrogryposis are usually autosomal recessive or autosomal dominant, rarely X-linked. Since the diagnostic yield is about 60%, a negative molecular genetic result does not exclude the clinical diagnosis.

Reference: https://www.ncbi.nlm.nih.gov/books/NBK1379/

https://www.ncbi.nlm.nih.gov/books/NBK2594/

https://www.ncbi.nlm.nih.gov/books/NBK567492/

 

Synonyms
  • Allelic: Alternating hemiplegia of childhood 1 (ATP1A2)
  • Allelic: Barrett esophagus/esophageal adenocarcinoma (ASCC1)
  • Allelic: CHAND syndrome (RIPK4)
  • Allelic: Cardiac valvular dysplasia, XL (FLNA)
  • Allelic: Cardiomyopathy, dilated, 1G (TTN)
  • Allelic: Cardiomyopathy, dilated, 1S (MYH7)
  • Allelic: Cardiomyopathy, dilated, 1X (FKTN)
  • Allelic: Cardiomyopathy, familial hypertrophic, 26 (FLNC)
  • Allelic: Cardiomyopathy, familial hypertrophic, 9 (TTN)
  • Allelic: Cardiomyopathy, familial restrictive 5 (FLNC)
  • Allelic: Cardiomyopathy, hypertrophic, 1 (MYH7)
  • Allelic: Congenital short bowel syndrome (FLNA)
  • Allelic: Developmental + epileptic encephalopathy 6B, non-Dravet (SCN1A)
  • Allelic: Developmental + epileptic encephalopathy 98 (ATP1A2)
  • Allelic: Dravet syndrome (SCN1A)
  • Allelic: Dystonia 27 (COL6A3)
  • Allelic: Dystonia-1, modifier of (TOR1A)
  • Allelic: Dystonia-1, torsion (TOR1A)
  • Allelic: Emery-Dreifuss muscular dystrophy 4, AD (SYNE1)
  • Allelic: Erythroleukemia, familial, susceptibility to (ERBB3)
  • Allelic: FG syndrome 2 (FLNA)
  • Allelic: Febrile seizures, familial, 3A (SCN1A)
  • Allelic: Focal segmental glomerulosclerosis 10 (LMX1B)
  • Allelic: Generalized epilepsy with febrile seizures plus, type 2 (SCN1A)
  • Allelic: Hardikar syndrome (MED12)
  • Allelic: Heterotopia, periventricular, 1 (FLNA)
  • Allelic: Immunodeficiency 9 (ORAI1)
  • Allelic: Intestinal pseudoobstruction, neuronal (FLNA)
  • Allelic: Larsen syndrome (FLNB)
  • Allelic: Left ventricular noncompaction 5 (MYH7)
  • Allelic: MEND syndrome (EBP)
  • Allelic: Macular degeneration, early-onset (FBN2)
  • Allelic: Malignant hyperthermia susceptibility 1 (RYR1)
  • Allelic: Mandibuloacral dysplasia with type B lipodystrophy (ZMPSTE24)
  • Allelic: Melnick-Needles syndrome (FLNA)
  • Allelic: Mental retardation, AD 13 (DYNC1H1)
  • Allelic: Migraine, familial basilar (ATP1A2)
  • Allelic: Migraine, familial hemiplegic, 2 (ATP1A2)
  • Allelic: Migraine, familial hemiplegic, 3 (SCN1A)
  • Allelic: Myasthenic syndrome, cong., 3C, ass. with acetylcholine receptor deficiency (CHRND)
  • Allelic: Myasthenic syndrome, congenital, 1A, slow-channel (CHRNA1)
  • Allelic: Myasthenic syndrome, congenital, 1B, fast-channel (CHRNA1)
  • Allelic: Myasthenic syndrome, congenital, 3A, slow-channel (CHRND)
  • Allelic: Myasthenic syndrome, congenital, 3B, fast-channel (CHRND)
  • Allelic: Myopathy, distal, 4 (FLNC)
  • Allelic: Myopathy, myofibrillar, 5 (FLNC)
  • Allelic: Orofacial cleft 6 (IRF6)
  • Allelic: Osteogenesis imperfecta, type XI (FKBP10)
  • Allelic: Polyglucosan body disease, adult form (GBE1)
  • Allelic: Retinitis pigmentosa 76 (POMGNT1)
  • Allelic: Sodium serum level QTL 1 (TRPV4)
  • Allelic: Spastic paraplegia, intellectual disability, nystagmus, obesity (KIDINS220)
  • Allelic: Spinocerebellar ataxia, AR 8 (SYNE1)
  • Allelic: Spondylocarpotarsal synostosis syndrome (FLNB)
  • Allelic: Visceral neuropathy, familial, 1, AR (ERBB3)
  • Allelic: Xeroderma pigmentosum, group G (ERCC5)
  • Allelic: Xeroderma pigmentosum, group G/Cockayne syndrome (ERCC5)
  • Allelic: van der Woude syndrome (IRF6)
  • Alkuraya-Kucinskas syndrome (KIAA1109 = BLTP1)
  • Alkuraya-Kucinskas syndrome [arthrogryposis, brain abnormalities] (KIAA1109)
  • Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis (POR)
  • Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis (FGFR2)
  • Arthrogryposis multiplex congenita 1, neurogenic, with myelin defect (LGI4)
  • Arthrogryposis multiplex congenita 2, neurogenic type (ERGIC1)
  • Arthrogryposis multiplex congenita 3, myogenic type (SYNE1)
  • Arthrogryposis multiplex congenita 5 (TOR1A)
  • Arthrogryposis multiplex congenita 6 (NEB)
  • Arthrogryposis multiplex congenita [panelapp] (SCN1A)
  • Arthrogryposis, Perthes disease, and upward gaze palsy (NEK9)
  • Arthrogryposis, distal, type 2A, Freeman-Sheldon (MYH3)
  • Arthrogryposis, distal, type 2B1 (TNNI2)
  • Arthrogryposis, distal, type 2B2 (TNNT3)
  • Arthrogryposis, distal, type 2B3, Sheldon-Hall (MYH3)
  • Arthrogryposis, distal, type 5D (ECEL1)
  • Arthrogryposis, renal dysfunction + cholestasis 1 (VPS33B)
  • Arthrogryposis, renal dysfunction + cholestasis 2 (VIPAS39)
  • Atelosteogenesis, type I (FLNB)
  • Atelosteogenesis, type III (FLNB)
  • Atelosteogenesis, types I, III; Boomerang dysplasia (FLNB)
  • Avascular necrosis of femoral head, primary, 2 (TRPV4)
  • Bethlem myopathy 1 (COL6A1-3)
  • Bethlem myopathy 2 (COL12A1)
  • Bohring-Opitz syndrome (ASXL1)
  • Boomerang dysplasia (FLNB)
  • Brachyolmia type 3 (TRPV4)
  • Bruck syndrome 1 (FKBP10)
  • Bruck syndrome 2 (PLOD2)
  • CAP myopathy 1 (TPM3)
  • CATSHL syndrome [CAmptodactyly, Tall Stature, Hearing Loss] (FGFR3)
  • Camptodactyly-arthropathy-coxa vara-pericarditis syndrome (PRG4)
  • Carey-Fineman-Ziter syndrome [hypotonia, Moebius + Pierre Robin complex, delayed motor] (MYMK)
  • Carney complex variant (MYH8)
  • Central core disease (RYR1)
  • Centronuclear myopathy 1 (DNM2)
  • Cerebrooculofacioskeletal syndrome 3 (ERCC5)
  • Charcot-Marie-Tooth disease, DI B (DNM2)
  • Charcot-Marie-Tooth disease, axonal type 2M (DNM2)
  • Charcot-Marie-Tooth disease, axonal, type 20 (DYNC1H1)
  • Chondrodysplasia punctata, XLD (EBP)
  • Cockayne syndrome, type A (ERCC8)
  • Cockayne syndrome, type B (ERCC6)
  • Cold-induced sweating syndrome 1 (CRLF1)
  • Congenital arthrogryposis with anterior horn cell disease (GLE1)
  • Congenital contractures of the limbs + face, hypotonia + developmental delay (NALCN)
  • Congenital disorder of glycosylation, type Id (ALG3)
  • Contractural arachnodactyly, congenital (FBN2)
  • Contractures, pterygia, + spondylocarpostarsal fusion syndrome 1A (MYH3)
  • Contractures, pterygia, + spondylocarpotarsal fusion syndrome 1B (MYh3)
  • Desmosterolosis (DHCR24)
  • Developmental + epileptic encephalopathy 69 (CACNA1E)
  • Digital arthropathy-brachydactyly, familial (TRPV4)
  • Distal arthrogryposis [panelapp] (ADAMTSL15)
  • Distal myopathy + posterior leg + anterior hand involvement [MONDO:0013550] (FLNC)
  • Ehlers-Danlos syndrome, kyphoscoliotic type, 1 (PLOD1)
  • Ehlers-Danlos syndrome, musculocontractural type 1 (CHST14)
  • Escobar syndrome (CHRNG)
  • Escobar syndrome [Lit.] (TPM2)
  • Fetal akinesia deformation sequence 3 (DOK7)
  • Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, dysmorphic facies (ATP1A2)
  • Frontometaphyseal dysplasia 1 (FLNA)
  • Gaucher disease, perinatal lethal (GBA)
  • Gaucher disease, type I, II, III, IIIC (GBA)
  • Genitopatellar syndrome (KAT6B)
  • Glycine encephalopathy with normal serum glycine (SLC6A9)
  • Glycogen storage disease IV (GBE1)
  • Glycogen storage disease VII (PFKM)
  • Hereditary motor + sensory neuropathy, type IIc (TRPV4)
  • Histiocytosis-lymphadenopathy plus syndrome (SLC29A3)
  • Hyaline fibromatosis syndrome (ANTXR2)
  • Hypomyelinating neuropathy, congenital, 3 (CNTNAP1)
  • Hypotonia, infantile, with psychomotor retardation + characteristic facies 1 (NALCN)
  • King-Denborough syndrome (RYR1)
  • Laing distal myopathy (MYH7)
  • Lethal congenital contractural syndrome 2 (ERBB3)
  • Lethal congenital contracture syndrome 1 (GLE1)
  • Lethal congenital contracture syndrome 10 (NEK9)
  • Lethal congenital contracture syndrome 11 (GLDN)
  • Lethal congenital contracture syndrome 5 (DNM2)
  • Lethal congenital contracture syndrome 7 (CNTNAP1)
  • Lethal congenital contracture syndrome 8 (ADCY6)
  • Lethal congenital contracture syndrome 9 (ADGRG6)
  • Loeys-Dietz syndrome 1 (TGFBR1)
  • Loeys-Dietz syndrome 2 (TGFBR2)
  • Loeys-Dietz syndrome 3 (SMAD3)
  • Loeys-Dietz syndrome 4 (TGFB2)
  • Loeys-Dietz syndrome 5 (TGFB3)
  • Lujan-Fryns syndrome (MED12)
  • Marden-Walker syndrome (PIEZO2)
  • Metatropic dysplasia (TRPV4)
  • Minicore myopathy with external ophthalmoplegia (RYR1)
  • Multiple pterygium syndrome, lethal type (CHRNA1, CHRND, CHRNG)
  • Muscular dystrophy, AR, with rigid spine + distal joint contractures (TOR1AIP)
  • Muscular dystrophy, cong., merosin deficient or partially deficient (LAMA2)
  • Muscular dystrophy, limb-girdle, AR 10 (TTN)
  • Muscular dystrophy, limb-girdle, AR 23 (LAMA2)
  • Muscular dystrophy, rigid spine, 1 (SELENON)
  • Muscular dystrophy-dystroglycanopathy limb-girdle), type C, 1 (POMT1)
  • Muscular dystrophy-dystroglycanopathy limb-girdle, type C, 12 (POMK)
  • Muscular dystrophy-dystroglycanopathy limb-girdle, type C, 14 (GMPPB)
  • Muscular dystrophy-dystroglycanopathy limb-girdle, type C, 2 (POMT2)
  • Muscular dystrophy-dystroglycanopathy limb-girdle, type C, 4 (FKTN)
  • Muscular dystrophy-dystroglycanopathy limb-girdle, type C, 5 (FKRP)
  • Muscular dystrophy-dystroglycanopathy limb-girdle, type C, 7 (CRPPA)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies), type A, 14 (GMPPB)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies), type A, 2 (POMT2)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies), type A, 6 (LARGE1)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 1 (POMT1)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 10 (RXYLT1)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 11 (B3GALNT2)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 12 (POMK)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 13 (B4GAT1)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 3 (POMGNT1)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 4 (FKTN)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 5 (FKRP)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 7 (CRPPA)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 8 (POMGNT2)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 9 (DAG1)
  • Muscular dystrophy-dystroglycanopathy, cong. with mental retardation), type B, 14 (GMPPB)
  • Muscular dystrophy-dystroglycanopathy, cong. with mental retardation), type B, 3 (POMGNT1)
  • Muscular dystrophy-dystroglycanopathy, cong. with mental retardation), type B, 6 (LARGE1)
  • Muscular dystrophy-dystroglycanopathy, cong. with mental retardation, type B, 1 (POMT1)
  • Muscular dystrophy-dystroglycanopathy, cong. with mental retardation, type B, 2 (POMT2)
  • Muscular dystrophy-dystroglycanopathy, cong. with/-out mental retardation, type B, 5 (FKRP)
  • Muscular dystrophy-dystroglycanopathy, cong. without mental retardation, type B, 4 (FKTN)
  • Muscular dystrophy-dystroglycanopathy, limb-girdle, type C, 3 (POMGNT1)
  • Muscular dystrophy-dystroglycanopathy, limb-girdle, type C, 9 (DAG1)
  • Myasthenic syndrome, congenital, 10 (DOK7)
  • Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency (RAPSN)
  • Myasthenic syndrome, congenital, 13, with tubular aggregates (DPAGT1)
  • Myasthenic syndrome, congenital, 16 (SCN4A)
  • Myasthenic syndrome, congenital, 20, presynaptic (SLC5A7)
  • Myasthenic syndrome, congenital, 25 (VAMP1)
  • Myasthenic syndrome, congenital, 2A, slow-channel (CHRNB1)
  • Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency (CHRNB1)
  • Myasthenic syndrome, congenital, 4A, slow-channel (CHRNE)
  • Myasthenic syndrome, congenital, 4B, fast-channel (CHRNE)
  • Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency (CHRNE)
  • Myasthenic syndrome, congenital, 5 (COLQ)
  • Myasthenic syndrome, congenital, 6, presynaptic (CHAT)
  • Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency (MUSK)
  • Myhre syndrome (SMAD4)
  • Myopathy, actin, congenital, with cores (ACTA1)
  • Myopathy, actin, congenital, with excess of thin myofilaments (ACTA1)
  • Myopathy, congenital, Baily-Bloch (STAC3)
  • Myopathy, congenital, with fast-twitch, type II, fiber atrophy (MYL1)
  • Myopathy, congenital, with fiber-type disproportion (SELENON)
  • Myopathy, congenital, with fiber-type disproportion (TPM3)
  • Myopathy, congenital, with fiber-type disproportion 1 (ACTA1)
  • Myopathy, myofibrillar, 9, with early respiratory failure (TTN)
  • Myopathy, myosin storage, AD (MYH7)
  • Myopathy, myosin storage, AR (MYH7)
  • Myopathy, scapulohumeroperoneal (ACTA1)
  • Myopathy, tubular aggregate, 2 (ORAI1)
  • Myosclerosis, congenital (COL6A2)
  • Myotubular myopathy, XL (MTM1)
  • Nail-patella syndrome (LMX1B)
  • Nemaline myopathy 1, AD/AR (TPM3)
  • Nemaline myopathy 10 (LMOD3)
  • Nemaline myopathy 2, AR (NEB)
  • Nemaline myopathy 3, AR/AD (ACTA1)
  • Nemaline myopathy 5, Amish type (TNNT1)
  • Nemaline myopathy 8, AR (KLHL40)
  • Nemaline myopathy 9 (KLHL41)
  • Neurodevelopmental disorder with microcephaly, arthrogryposis + structural brain anomalies (SMPD4)
  • Neuromuscular disease, congenital, with uniform type 1 fiber (RYR1)
  • Neuronopathy, distal hereditary motor, type VIII (TRPV4)
  • Ohdo syndrome, XL (MED12)
  • Opitz-Kaveggia syndrome (MED12)
  • Otopalatodigital syndrome, type I (FLNA)
  • Otopalatodigital syndrome, type II (FLNA)
  • PERCHING syndrome [global developm. delay, dysmorphic face, poor growth, contractures] (KLHL7)
  • Parastremmatic dwarfism (TRPV4)
  • Peroxisome biogenesis disorders (PEX1-3, PEX5-7, PEX10-14, PEX16, PEX19, PEX26)
  • Pontocerebellar hypoplasia type 2A (TSEN54)
  • Pontocerebellar hypoplasia type 4 (TSEN54)
  • Pontocerebellar hypoplasia type 5 (TSEN54)
  • Pontocerebellar hypoplasia, type 1B (EXOSC3)
  • Popliteal pterygium syndrome 1 (IRF6)
  • Popliteal pterygium syndrome, Bartsocas-Papas type (RIPK4)
  • Proximal myopathy + ophthalmoplegia (MYBPC1)
  • Proximal myopathy + ophthalmoplegia (MYH2)
  • Raine syndrome [neonatal osteosclerotic bone dysplasia] (FAM20C)
  • Restrictive dermopathy, lethal (ZMPSTE24)
  • SED, Maroteaux type (TRPV4)
  • Salih myopathy (TTN)
  • Scapuloperoneal spinal muscular atrophy (TRPV4)
  • Scapuloperoneal syndrome, myopathic type (MYH7)
  • Schaaf-Yang syndr. [delayed psychomotor/intell. developm., hypotonia, behav. abnorm.] (MAGEL2)
  • Schwartz-Jampel syndrome, type 1 (HSPG2)
  • Shprintzen-Goldberg syndrome [craniosynostosis, marfanoid, skeletal, neurologic, cardiovasc.] (SKI)
  • Spinal muscular atrophy with congenital bone fractures 2 (ASCC1)
  • Spinal muscular atrophy, XL 2, infantile (UBA1)
  • Spinal muscular atrophy, lower extremity-predominant 1, AD (DYNC1H1)
  • Spinal muscular atrophy, lower extremity-predominant, 2A, AD (BICD2)
  • Spinal muscular atrophy, lower extremity-predominant, 2B, AD (BICD2)
  • Spinal muscular atrophy-0, -1, -2, -3, -4 (SMN1)
  • Spondylometaphyseal dysplasia, Kozlowski type (TRPV4)
  • Stormorken syndrome [bleeding, thrombocytopenia, anemia, asplenia, tub. aggr. myopathy...] (STIM1)
  • Terminal osseous dysplasia (FLNA)
  • Tibial muscular dystrophy, tardive (TTN)
  • Ullrich congenital muscular dystrophy 1 (COL6A1-3)
  • Ullrich congenital muscular dystrophy 2 (COL12A1)
  • Van den Ende-Gupta syndrome [contractual arachnodactyly + distinctive face] (SCARF2)
  • Ventriculomegaly and arthrogryposis (KIDINS220)
  • Weill-Marchesani syndrome 1, recessive (ADAMTS10)
  • Wieacker-Wolff syndrome [severe neurodevelopmental disorder affecting CNS + PNS] (ZC4H2)
Heredity, heredity patterns etc.
  • AD
  • AR
  • XL
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatics and clinical interpretation

Test-Stärken

  • DAkkS-akkreditiertes Labor
  • EU-Richtlinie für IVD in Umsetzung
  • Qualitäts-kontrolliert arbeitendes Personal
  • Leistungsstarke Sequenzierungstechnologien, fortschrittliche Target-Anreicherungsmethoden und Präzisions-Bioinformatik-Pipelines sorgen für überragende analytische Leistung
  • Sorgfältige Kuratierung klinisch relevanter und wissenschaftlich begründeter Gen-Panels
  • eine Vielzahl nicht Protein-kodierender Varianten, die in unseren klinischen NGS-Tests mit erfasst werden
  • unser strenges Variantenklassifizierungsschema nach ACMG-Kriterien
  • unser systematischer klinischer Interpretations-Workflow mit proprietärer Software ermöglicht die genaue und nachvollziehbare Verarbeitung von NGS-Daten
  • unsere umfassenden klinischen Aussagen

Testeinschränkungen

  • Gene mit eingeschränkter Abdeckung werden gekennzeichnet
  • Gene mit kompletten oder partiellen Duplikationen werden gekennzeichnet
  • es wird angenommen, dass ein Gen suboptimal abgedeckt ist, wenn >90% der Nukleotide des Gens bei einem Mapping-Qualitätsfaktor von >20 (MQ>20) nicht abgedeckt sind
  • die Sensitivität der Diagnostik zur Erkennung von Varianten mit genannten Testeinschränkungen ist möglicherweise begrenzt bei:
  • Gen-Konversionen
  • komplexe Inversionen
  • Balancierte Translokationen
  • Mitochondriale Varianten
  • Repeat-Expansionen, sofern nicht anders dokumentiert
  • nicht kodierende Varianten, die Krankheiten verursachen, die von diesem Panel nicht mit abgedeckt werden
  • niedriger Mosaik-Status
  • Repeat-Blöcke von Mononukleotiden
  • Indels >50bp (Insertionen-Deletionen)
  • Deletionen oder Duplikationen einzelner Exons
  • Varianten innerhalb von Pseudogenen
  • die analytische Sensitivität kann geringer ausfallen werden, wenn die DNA nicht von amedes genetics extrahiert wurde

Laboratory requirement

  • Die in grün gezeigten Gene sind kuratiert und werden als Gen-Panel untersucht. Eine Erweiterung des Panels (blau gezeigte Gene, jeweils ebenfalls kuratiert) kann auf Anfrage erfolgen. Sofern unter "Erweitertes Panel" ein Minuszeichen angezeigt wird, sind nur Core-/Basis-Gene verfügbar.

  • Für die Anforderung einer genetischen Untersuchung senden Sie uns bitte die Krankheits-ID auf einem Überweisungsschein. Bitte die Material-Angabe beachten.

  • Für privat versicherte Patienten empfehlen wir einen Antrag auf Kostenübernahme bei der Krankenversicherung.

  • Die Untersuchung wird auch für Selbstzahler angeboten.